Can you provide the average price target for BIOCARDIA INC stock?
8 analysts have analysed BCDA and the average price target is 15.81 USD. This implies a price increase of 1217.5% is expected in the next year compared to the current price of 1.2.
BIOCARDIA INC (BCDA) Forecast, Price Target & Analyst Ratings
NASDAQ:BCDA • US09060U6064
Current stock price
1.2 USD
-0.05 (-4%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIOCARDIA INC (BCDA).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 13, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.17
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
$15.81
Upside
+ 1,217.50%
From current price of $1.20 to mean target of $15.81, Based on 8 analyst forecasts
Low
$6.06
Median
$15.81
High
$26.25
Price Target Revisions
1 Month
-38.00%
3 Months
0.00%
Price Target Summary
8 Wall Street analysts provided a forecast for the next 12 months for BCDA. The average price target is 15.81 USD. This implies a price increase of 1217.5% is expected in the next year compared to the current price of 1.2.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.50%
BCDA was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about BCDA.
In the previous month the buy percentage consensus was at a similar level.
BCDA was analyzed by 8 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-09-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-16 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-07-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-30 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-11-11 | Dawson James | Downgrade | Buy -> Neutral |
| 2021-12-20 | HC Wainwright & Co. | Initiate | Buy |
| 2021-04-16 | Dawson James | Downgrade | Buy -> Neutral |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 13, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.17
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- 71.47%
- Number of Analysts
- 4
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
BCDA is expected to report earnings on 5/13/2026. The consensus EPS estimate for the next earnings is -0.17 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates 2026 - 2028
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.35M 32.35% | 477K -64.67% | 58K -87.84% | -100.00% | 4.233M | |||
| EBITDA YoY % growth | -11.82M 5.97% | -11.56M 2.20% | -7.934M 31.37% | -8.67M -4.03% | -9.996M -21.10% | -12.24M -22.45% | -8.976M 26.67% | |
| EBIT YoY % growth | -11.9M 5.78% | -11.644M 2.15% | -8.001M 31.29% | -8.295M -3.46% | -8.415M -1.65% | -10.557M -25.45% | -8.976M 14.98% | |
| Operating Margin | -881.48% | -2,441.09% | -13,794.83% | N/A | N/A | N/A | -212.05% | |
| EPS YoY % growth | -10.05 9.46% | -8.25 17.91% | N/A 61.55% | -1.17 59.33% | -0.64 50.19% | -0.52 19.84% | -0.40 22.77% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.17 71.47% | -0.17 56.65% | -0.15 38.38% | -0.15 -155.00% |
| Revenue Q2Q % growth | ||||
| EBITDA Q2Q % growth | -1.938M 28.59% | -2.346M -15.34% | -2.652M -4.00% | -3.06M -53.85% |
| EBIT Q2Q % growth | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
19.15%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
-2.66%
EBIT Next 5 Year
N/A
BIOCARDIA INC / BCDA Forecast FAQ
Can you provide the upcoming earnings date for BIOCARDIA INC?
BIOCARDIA INC (BCDA) will report earnings on 2026-05-13.
What are the consensus estimates for BCDA stock next earnings?
The consensus EPS estimate for the next earnings of BIOCARDIA INC (BCDA) is -0.17 USD and the consensus revenue estimate is 0 USD.
How many analysts cover BIOCARDIA INC (BCDA) stock?
The number of analysts covering BIOCARDIA INC (BCDA) is 8.